Skip to main content
VCbacked
Log inGet Started

Beeline Medicines

Boston, United States

Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.

$300.0M raised
Apr 2026
Series A
BiotechnologyHealth CareTherapeutics

Top Investors

Bain Capital

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Beeline Medicines

How much funding has Beeline Medicines raised?
Beeline Medicines has raised $300.0M in total funding. The most recent round was Series A. The last funding was announced in April 2026.
Who are Beeline Medicines's investors?
Beeline Medicines's investors include Bain Capital.
Where is Beeline Medicines headquartered?
Beeline Medicines is headquartered in Boston, United States.
What does Beeline Medicines do?
Beeline Medicines is a biotechnology company that identifies and provides precise treatments to autoimmune inflammatory disorders.
What stage is Beeline Medicines at?
Beeline Medicines is at the Series A stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Beeline Medicines — Funding & Investors." VCBacked, April 15, 2026, https://www.vcbacked.co/company/beeline-medicines. Accessed July 4, 2026.
APA
VCBacked. (2026). Beeline Medicines — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/beeline-medicines
Wikipedia (cite web)
{{cite web |title=Beeline Medicines — Funding & Investors |url=https://www.vcbacked.co/company/beeline-medicines |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Rapport Therapeutics
Boston$250.0M
Allterum Therapeutics
Houston$1.0M
AlpalifeBio
Woburn$9.8M
Renaissance BioScience
Vancouver$599K
Epsilogen
London$16.3M
Advanced Microbiome Interventions
Amsterdam$300K